 |
 |

TREATMENT OF PNEUMONIA WITH SULFAPYRIDINEOBSERVATIONS ON TOXIC REACTIONS
H. K. DETWEILER, M.D.;
H. I. KINSEY, M.B.;
W. HURST, D.M.;
W. R. FEASBY, M.D.
Arch Intern Med. 1940;65(6):1144-1157.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
Since the appearance, in 1938. of favorable reports1 on the use of sulfapyridine (2-[paraaminobenzenesulfonamido]-pyridine) in the treatment of pneumococcic pneumonia, attention has been focused on this substance. Agreement on its usefulness has been general, but little mention has been made of the serious toxic manifestations which may attend its use. It is chiefly by reason of the latter fact that we are making a report on a small series of cases.
SELECTION OF CASES
Sulfapyridine became available in this hospital in October 1938,1a at a time when we were still engaged in evaluating antipneumococcus rabbit serum in the therapy of pneumonia. This work was continued until mid-December. Until that time, therefore, patients with pneumonia were divided into three groups: those who were being treated with serum, those who were treated with sulfapyridine and controls. This accounts for the small number of patients treated with sulfapyridine up to that
. . . [Full Text PDF of this Article]
Author Affiliations
TORONTO, CANADA
From the Department of Medicine, University of Toronto, and the Medical Service, Toronto Western Hospital.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|